Milestone Pharmaceuticals Faces FDA Regulatory Risks, Stock Target Suggests High Upside Milestone Pharmaceuticals (MIST) is navigating potential operational delays stemming from regulatory scrutiny, according to a recent disclosure. The company …
indices
-
-
Alibaba’s AI-Driven Transformation: Cloud Growth Outpaces E-Commerce Alibaba Group Holding Limited is undergoing a significant shift, with artificial intelligence (AI) rapidly becoming a key driver of growth, particularly within its …
-
Entertainment
Universal Logistics (ULH) Price Target & Rating Update | J. Bruce Chan, Stifel Nicolaus
Stifel Analyst Maintains Hold Rating on Universal Logistics On Wednesday, March 18, 2026, J. Bruce Chan, an analyst at Stifel, reiterated a Hold rating on Universal Logistics (ULH). The price …
-
Vertex Pharmaceuticals: Beyond Cystic Fibrosis and Toward a $600 Valuation? Vertex Pharmaceuticals (NASDAQ: VRTX) has experienced significant growth in recent years, expanding beyond its established leadership in cystic fibrosis (CF) …
-
Eupraxia Pharmaceuticals Receives Positive Analyst Ratings Amidst Insider Activity Eupraxia Pharmaceuticals (NASDAQ: EPRX) is attracting positive attention from financial analysts and demonstrating encouraging signals from corporate insiders, suggesting potential growth …
-
Berkshire Hathaway’s Portfolio: Apple, American Express, and the Fate of Kraft Heinz Warren Buffett stepped down as CEO of Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB) at the end of 2025. Still, …
-
Navigating the Cryptocurrency Landscape: Ethereum, World Liberty Financial, and Dogecoin The cryptocurrency market presents a complex landscape of opportunities and risks. While some digital assets demonstrate genuine potential, others are …
-
Beyond Nvidia: Diversifying Your AI Investment Portfolio Artificial intelligence (AI) is rapidly transforming the technological landscape, creating substantial investment opportunities. While Nvidia currently dominates headlines and market share, a broader …
-
Sony Expands Share Repurchase Program to ¥250 Billion Sony Group Corporation announced an expansion of its share repurchase facility to ¥250 billion (approximately $1.6 billion USD as of February 26, …
-
Micron’s AI Advantage: Poised to Outperform Alphabet Artificial intelligence (AI) has develop into a major catalyst for growth across the tech sector, significantly benefiting companies like Alphabet. Still, Micron Technology …